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A mouse lymphocyte receptor for antibody complexed to antigen has been 
described  by  several  laboratories  (1-5).  The  receptor  appeared  to  be  char- 
acteristic of bone marrow-(or nonthymus)-derived (B)  lymphocytes; binding 
to the receptor was apparently complement independent; the receptor formed 
a  stable  bond  to  antibody only when  the  latter  was  complexed to  antigen; 
binding to the receptor was not inhibited by antimouse immunoglobulin; and 
the receptor appeared to have binding specificity for the Fc portion of the anti- 
body molecule. 
In what  appears to be an analogous observation, a  human lymphocyte re- 
ceptor for heat-aggregated immunoglobulin (Ig) complexes has been described 
(6-9).  In normal human peripheral blood, the receptor was found on both B 
cells and a small subpopulation of lymphocytes (mean 3.6%) which bore both 
thymus-derived (T)  and  B-cell markers.  In  certain cases of chronic lympho- 
cytic leukemia or hypogammaglobulinemia, the receptor was detected on some 
peripheral blood lymphocytes (PBL)  ~ which appeared to be B  cells but which 
lacked easily detectable surface Ig.  The binding  of aggregated Ig  to  this  re- 
ceptor was  not dependent on complement,  divalent  cations,  or  temperature, 
and was not inhibited by polyvalent (% #, K, X) anti-Ig. 
The  present  studies  were  carried  out  to  further  characterize  the  human 
lymphocyte receptor for complexed Ig. Data from these studies indicate that: 
(a)  the receptor has specificity for the Fc portion of complexed Ig, and it ap- 
pears  that  the site on  the Fc is dependent on disulfide bond(s);  (b)  heat-ag- 
gregated Ig and antigen-complexed Ig bind to the same receptor; (c) the receptor 
for complexed antibody is distinct from surface Ig and appears to be a trypsin- 
resistant  protein or  glycoprotein;  (d)  membrane-bound Ig  complexes do not 
readily accumulate at one pole of the cell (cap formation) unless they are sub- 
sequently cross-linked with  anti-Ig; (e) the receptor is necessary for antibody- 
* A portion of this work was supported by contract no. NIH-N01-CB-02207. 
1  Abbreviations used in this paper: BSA-PBS, 2% bovine serum albumin in phosphate- 
buffered saline, pH 7.2 or 8.0 with or without Na Azide 0.02%; FCS, fetal calf serum; FITC, 
fluorescein isothiocyanate; f/p, absorption ratio (495 nm or 515 nm/280 rim); HSA human 
serum albumin; KLH, keyhole limpet hemocyanin; PBS, phosphate-buffered saline, pH  7.2 
or 8.0, 0.05 M PO4 and 0.15 M NaC1; TMRITC,  tetramethylrhodamine isothiocyanate. 
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dependent  lymphocyte-mediated cytotoxicity; and  (f)  there may be more than 
one  kind  of  lymphocyte  receptor  for complexed  antibody  and/or  lymphocyte 
subpopulations  which bear  the  receptor. 
Materials and Methods 
Aggregated Human Ig.--Cohn Fraction II human Ig and IgG prepared by DEAE-¢ellulose 
chromatography  (both from Miles Laboratories, Inc., Miles Research Div., Kankakee, Ill.) 
were dissolved in phosphate-buffered  saline 0.05  M  PO4, 0.15  M  NaCl  (PBS),  pH  7.2,  at 
concentrations of 10-50  mg/ml. For conjugation of Ig to fluorescein  isothiocyanate (FITC), 
10~  (vol/vol) carbonate bicarbonate buffer,  0.5 M, pH 9.0, was added, the pH corrected to 
9.0 with 1 N  NaOH, and FITC (Baltimore Biological Laboratories, Cockeysville, Md.), 20 
#g/rag, protein added. The preparation was incubated and stirred for 18 h at 4°C, and then 
exhaustively dialyzed with  PBS,  pH  7.2,  to remove unconjugated  FITC. The absorption 
495 nm/280 nm (f/p) ratios of conjugated preparations were between 1.0 and 1.1. Conjugated 
and  unconjugated  preparations  were heat aggregated  at  63°C  for  20  rain  and  pelleted  at 
145,000 g for 1 h at 4°C. The supernate was discarded; the pellet (~20-25% of the starting 
material)  homogenized in PBS, pH 8.0,  in a  7-ml Dounce homogenizer (Kontes  Glass  Co., 
Vineland, N. J.) and the pH corrected to 8.1 with 0.1 N  NaOH. Just before  use  aggregates 
were centrifuged at 600 g for 15 min at 4°C, and adjusted to appropriate concentrations  (see 
below) with PBS, pH 8.0. For certain experiments, aggregates of specific size and  deaggregated 
7S Ig and  IgG were obtained by preparative ultracentrifugation as described by  Trautman 
and Cowan (10). 
A ggregated Proteins. -Crystallized bovine serum albumin (BSA), crystallized human serum 
albumin  (HSA), and  human  transferrin  (all from Miles Laboratories,  Inc., Miles Research 
Div.) were dissolved in  PBS, pH  7.2, at 20 mg/ml and  conjugated  to FITC by  the same 
methods as those used for Ig except that 10/zg FITC/mg protein was used for BSA and HSA. 
f/p ratios were: BSA, 1.2; HSA, 1.0; and transferrin, 1.2. In order to produce the same degree 
of aggregation as obtained with Ig (as judged by sedimentation rate during subsequent cen- 
trifugation), the proteins were heated as follows: BSA, 80°C, 20 min; HSA, 70°C, 20 rain; and 
transferrin,  70°C, 20 rain.  After heating, the proteins were further processed  as described for 
aggregated Ig. Protein aggregates similar in size to Ig aggregates were obtained by preparative 
ultracentrifugation (10). 
Chemically Modified Ig.--Chemical modifications were performed on Cohn Fraction II Ig. 
F(ab~)2  fragment was prepared  by pepsin  digestion  (1:50  ratio pepsin  to protein)  by  the 
published  methods  (11),  and  separation  by Sephadex  G-150 gel filtration  (Pharmacia Fine 
Chemicals, Inc., Piscataway, N. J.). Mild oxidation was performed by adding H202 (1.0 mM 
final concentration) to Ig (10 mg/ml PBS, pH 7.2) for 2 h at 23°C followed  by dialysis with 
PBS, pH 7.2. Reduction and  alkylation was performed as described by Wiedermann et al. 
(12).  Modified Ig preparations  were conjugated to FITC and  heat aggregated as described 
for Ig, and  aggregates similar in size  to Ig aggregates were obtained  by preparative ultra- 
centrifugation (10). 
Antigen-Antibody  Complexes.--Keyhole  limpet hemocyanin  (KLH)  and  rabbit  antibody 
to KLH purified by affinity chromatography were kindly provided by Dr.  Michael  Blaese, 
Metabolism Branch, National Cancer Institute, Bethesda, Md. Both KLH and anti-KLH were 
dialyzed into PBS, pH 8.0, and KLH was conjugated to FITC as described for Ig. Preliminary 
experiments showed that neither KLH nor anti-KLH alone would bind to lymphocytes,  and 
that complexes preformed at equivalence or in antigen excess caused clumping of cells.  Com- 
plexes were therefore preformed in antibody excess (molar basis)  by combining equal amounts 
of KLH (0.4 mg/ml) and anti-KLH (0.4 mg/ml) and incubating for 30 rain at 23°C. 
Anti-Ig Antiserum.--A polyvalent (#, 7, a,  •,  X), unabsorbed,  antihuman  Ig antiserum 
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obtained from Cappel Laboratories, Downingtown, Pa.  (lot no.  6481). The antiserum was 
tested for specificity by immunoelectrophoresis and Ouchterlony double diffusion. Specificity 
was also demonstrated by loss of activity after absorption with insolubilized purified Ig 0z, ~', 
a, K, k). The antiserum was reconstituted with PBS, pH 7.2, had an f/p absorption 515 nm/280 
nm ratio of 0.36, and was deaggregated by preparative ultracentrifugation immediately before 
use (10). 
Lymphocyte  Separation.--Mononuclear  cells were  isolated  from  the  peripheral  blood  of 
normal humans by density flotation as described by B6yum  (13). The mononuclear cells  (up 
to 10 s) were washed three times with PBS, pH 7.2, and, in order to remove monocytes, resus- 
pended in 5 ml of 100% autologous serum, passed onto 200 nag of nylon fiber (Fenwal Labora- 
tories, Morton Grove, Ill.), loosely packed to the 8 ml mark of a !0 ml disposable glass syringe 
(Becton, Dickinson & Co., Rutherford, N. J.), and incubated at 37°C for 30 min. Cells were 
then eluted with 25 ml of PBS, pH 7.2, washed once, and again resuspended in 100%  autolo- 
gous serum (2 X  107/ml). In order to assess residual phagocytic cells, 1-#m polystyrene beads 
(Dow Diagnostics, Indianapolis, Ind.) were added  (2 mg/ml); the cell suspension was mixed 
and incubated at 37°C for 30 rain. The cells were then washed three times with PBS, pH 7.2, 
and  resuspended  as  required  for  various  assays  (see  below).  Final preparations contained 
99.7% lymphocytes (as determined by morphology and phagocytosis) and were )>99% viable 
(trypan blue exclusion). Yields were ~60% and minimal selective loss of B lymphocytes was 
noted (8). 
Fluorescence.--For immunofluorescent staining of lymphocyte surface Ig, isolated lympho- 
cytes were suspended at 20 X  106/ml in 2% BSA-PBS, 0.02% Na azide, pH 7.2  (BSA-PBS, 
pH 7.2), and TMRITC-conjugated anti-Ig antiserum was used at 1.2 mg/ml. Antiserum and 
cells (0.05 ml of each) were mixed and incubated at 4°C for 30 min. The cells were then washed 
three  times with  10  vol excess  of BSA-PBS,  pH  7.2,  vigorously resuspended  (to prevent 
clumping) in the same medium, and wet mounts prepared. 
Fluorescent detection of complex binding was performed as described for Ig staining except 
that BSA-PBS, pH  8.0, was used and the incubation was at 23°C. ~ Preparations of FITC- 
conjugated and heat-aggregated Ig, chemically modified Ig, and other proteins (see above), 
were used at 1.0 mg/ml; preformed FITC-conjugated KLH-anti-KLH  complexes were used 
at 0.4 mg/ml. 
Microscopy was performed on a  Leitz  orthoplan microscope  (E.  Leitz,  Inc., Rockleigh, 
N. J.) equipped with a  Ploem vertical illuminator, D. C. power source and H. B. O.  100 W 
mercury arc lamp, Heine phase condenser and 90X/1.32 N. A. apochromatic oil immersion 
objective, and a  monocular head. The excitation filters for FITC were: one BG 38, two KP 
490's, and one K475; and for TMRITC: one BG 38 and three S 546's (Type AL). Dichroic 
mirror/suppression filters for FITC were: TK 510/K515, and for TMRITC: TK 580/K 580. 
These  filter  combinations allowed  detection  of  the  indicated  fluorochrome  with  absolute 
selectivity. Microscopic fields were read alternately under phase and UV illumination for the 
percentage of fluorescent-positive lymphocytes. The criterion for positive fluorescence with 
anti-Ig was uniform punctate surface staining, and for complexes was 3 or more fluorescent 
complexes bound/cell. Only cells which appeared to be lymphocytes by morphologic criteria 
and which had neither phagocytized nor adhered polystrene beads were counted. A minimum 
of 200 lymphocytes were counted/preparation and reproducibility was  ~2%. 
Alterations of Cell Surface Antigens.- 
Modulation:  Isolated lymphocytes were labeled with either TMRITC-conjugated anti-Ig 
or FITC-conjugated  heat-aggregated  Ig  as described above except no Na  azide was  used. 
After washing three times the cells were resuspended  (106/ml) in Eagle's no. 2 medium con- 
2 Binding of complexes at pH 8.0 and 23°C produces a more uniform staining pattern with 
small complexes being distributed over the entire cell surface. This is in contrast to the clumpy 
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taining 20%  (vol/vol) heat-inactivated fetal calf serum  (FCS). After incubation at 37"C for 
various periods of time, the cells were washed with BSA-PBS containing Na azide and wet 
mounts were prepared. In certain experiments samples of the modulated cells were restained 
with the same reagent or tested with the second reagent. 
Enzymatic Treatment:  Isolated lymphocytes (107/ml  in Hanks' balanced salt solution) 
were incubated for 20 rain at 37°C in the presence of trypsin, 2 or 10 mg/ml, (Grade V, Miles 
Laboratories, Inc., Miles Research  Div.), or pronase,  1 mg/ml, (Type VI, Sigma Chemical 
Co., St. Louis, Mo.). The cells were then washed three times and assayed for surface Ig and 
aggregated Ig binding as described above. 
A ntibody-Dependent Lymphocyte-Mediated Cytotoxidty.--The assay utilized has been  de- 
scribed in detail elsewhere  (14). Briefly, isolated nonimmune  lymphocytes (attackers) were 
mixed in suspension  with  51Cr-labeled lymphocytes coated with antibody from  a multiply 
transfused  patient (targets). After a 4-h incubation at 37°C the suspensions were centrifuged 
and supernatant samples counted for  51Cr. Immune activity was gauged  by "% lysis", the 
amount of  51Cr released  from  target cells by attacking lymphocytes relative to maximal 
releasable 51Cr as determined by freeze-thaw of the targets. Results were corrected for spon- 
taneous release of SlCr from targets incubated with media alone. Quadruplicate samples were 
used and standard errors of the mean  (SEM) calculated. 
The effect of lymphocyte-bound Ig complexes on this immune  activity was evaluated by 
preincubating attacker lymphocytes with various amounts of heat-aggregated IgG  (or, as 
controls,  7S IgG or medium)  as described  above,  for the binding  of fluorescent  complexes. 
No Na azide was present and the lymphocytes were thoroughly washed to remove unbound 
complexes before use in the cytotoxic assay. 
RESULTS 
Specificity of the Receptor.--To  determine whether  the property of binding 
of heat-aggregated Ig to the lymphocyte receptor was shared by other proteins, 
FITC-conjugated and heat-aggregated HSA, BSA, and human transferrin were 
prepared so as to be equivalent to the Ig aggregates (size, concentration,  and 
f/p  ratio). The  various protein  aggregate preparations were  then  assayed for 
binding to normal  human  PBL  (Table I).  Aggregated Ig bound  to  the same 
percentage of lymphocytes as that which  bore surface Ig. These two  markers 
have  previously been  shown  to  be  on  the  same  ceils,  which  are primarily B 
lymphocytes  (6,  8).  In  contrast,  only  a  rare  lymphocyte  bound  any  of  the 
other aggregated proteins, indicating that  the receptor would not  bind every 
type of aggregated protein and appeared to be specific for complexed Ig. 
The nature of the site(s) on the Ig molecule recognized by the receptor was 
examined by assaying the binding to PBL of aggregates prepared from Ig which 
had been chemically modified. As shown in Table II, lymphocytes did not bind 
aggregated Ig which  lacked  the  Fc portion  of  the  molecule  (F(abt)2),  or  ag- 
gregates prepared from Ig with modified disulfide bonds (reduced and alkylated 
Ig, oxidized Ig).  3 These studies provided evidence that the receptor recognizes 
a  site on  the Fc portion of complexed Ig, and that the integrity of this site is 
dependent upon intact disulfide bond(s). 
3 Hydrogen peroxide is a relatively nonspecific oxidizing agent capable of modifying several 
amino acid residues including disulfide bonds  (15), whereas  reduction and alkylation with 
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TABLE I 
Binding of Heat-Aggregated Proteins to Normal Human Peripheral Blood Lymphocytes 
Protein* 
% Positive~ 
Exp. 1§  Exp. 2 
Human Ig  16.5  24.5 
HSA  <0.1  0.1 
Human transferrin  0.3  0.5 
BSA  0.2  O.6 
Antihuman Ig  16.0  25.0 
* Proteins were conjugated to FITC, heat aggregated, and preparatively ultracentrifuged 
(see Materials and Methods) so as to be equivalent (size, f/p ratio, and concentration). 
~t 300-1,000 cells evaluated/preparation. 
§ Different preparations of each of the proteins as well as a different blood donor were 
used in the two experiments. 
TABLE II 
Binding of Chemically Modified  and Heat-Aggregated Ig to Normal Human Peripheral  Blood 
L ym  p hoc  y tes 
Preparation* 
% Positive~ 
Exp. 1§  Exper. 2 
Ig  24.0  15.5 
F(ab')2  0.5  <0.5 
Reduced and alkylated Ig  0.5  1.0 
Oxidized Ig  1.5  0.5 
Antihuman Ig  23.5  16.5 
* For details of chemical modifications  see  Materials and Methods.  Preparations were 
conjugated to FITC, heat aggregated, and preparatively ultracentrifuged (see Materials and 
Methods) so as to be equivalent (size, f/p ratio, and concentration). 
~t Minimum of 200 cells evaluated/preparation. 
§ The two experiments used different blood donors and separately modified Ig's. 
To  assess  whether  the  same  receptor  bound  both  heat-aggregated Ig  and 
antigen-antibody complexes,  the  latter were  preformed with  affinity chroma- 
tography purified rabbit  anti-KLH  and  FITC-conjugated  KLH.  When  such 
complexes were  examined  for  binding to  lymphocytes  (Table III),  the  same 
percentage  of  PBL  bound  KLH-anti-KLH  as bound  heat-aggregated Ig and 
stained for surface Ig. In addition, inhibition studies were performed, in which 
lymphocytes were  incubated  with  unconjugated  KLH-anti-KLH  or  heat-ag- 
gregated Ig, washed thoroughly, and then incubated with the alternate complex 
conjugated  to  FITC.  The  results  are presented in Table  IV.  The  binding of 
aggregated Ig inhibited the binding of KLH-anti-KLH (exp. 8 vs. 3)  and vice 
versa  (exp.  10  vs.  2).  Inhibition was  never  complete  (~70%),  but  a  similar HOWARD  13.  DICKLER  513 
TABLE III 
Comparison of Heat-Aggregated Ig and A ntigen-Antibody  Complex Binding  to Normal Human 
Peripheral Blood Lymphocytes 
Donor 
% Positive* 
Aggregated Ig  Anti-KLH-KLH 
Surface Ig  binding  binding  ~: 
J.C.  30.0  29.0  29.0 
P.H.  24.0  23.5  25.5 
H.D.  14.0  15.5  15.0 
R.H.  9.0  9.0  9.5 
* Minimum of 200 cells evaluated/preparation. 
:~ KLH-Anti-KLH complexes were preformed  (see Materials  and Methods). 
TABLE IV 
Cross Inhibition  of Binding  to Lymphocytes Between Heat-A ggregated Ig and A ntigen-Antibody 
Complexes 
Exp.  1st incubation*  2nd incubation~t  % Positive§ 
1  Medium  Anti-Ig  24.5 
2  Medium  Aggregated Ig  24.0 
3  Medium  KLH-anti-KLH  26.5 
4  Anti-KLH  Aggregated Ig  23.5 
5  KLH  Aggregated Ig  26.0 
6  KLH-anti-KLH  Anfi-Ig  25.0 
7  Aggregated Ig  Aggregated Ig  6.5 
8  Aggregated Ig  KLH-anti-KLH  8.0 
9  KLH-anti-KLH  KLH-anti-KLH  8.5 
I0  KLH-anti-KLH  Aggregated Ig  6.0 
* Reagents  for 1st incubation  were not conjugated  with a fluorescent isomer. 
:~ Lymphocytes washed three  times  between incubations.  Reagents  for 2nd  incubation 
were conjugated  to FITC (aggregated Ig and KLH-anti-KLH) or TMRITC(anti-Ig). 
§ Minimum of 200 cells evaluated/preparation. 
lack of complete inhibition  was noted when  homologous complexes were used 
(exps.  7 and 9). This was presumed  to be due to the heterogeneity in the size 
of the complexes such that some small complexes bound during the first incuba- 
tion  could  be  displaced  by  larger  complexes  during  the  second  incubation. 
Other  controls  showed  that  neither  antigen  or  antibody  alone  inhibited  the 
binding  of  aggregated  Ig  (exps.  4  and  5),  and  that  the  binding  of  antigen- 
antibody  complexes  did  not  interfere  with  the  ability  to  detect  surface  Ig 
(exp.  6). Thus, it appeared that the same receptor was responsible for binding 
both antigen-antibody complexes and heat-aggregated Ig. 
Chemical Nature of the Receptor.--In order to examine the question of whether 
the  receptor  for  complexed  Ig  and  lymphocyte  surface  Ig  were  associated, 
capping  experiments  were performed.  PBL were  labeled  with  TMRITC-con- 514  STUDIES  OF  THE  LYMPHOCYTE  RECEPTOR  FOR  COMPLEXED  Ig 
jugated  anti-Ig, washed,  and then incubated in medium containing  FCS for 2 
h  at 37°C.  After such treatment fluorescence was usually seen as a  cap at one 
pole of the cell as described by Taylor et al. (17). If capped cells were relabeled 
with the same reagent, no staining was seen outside the cap. In contrast, when 
capped  cells  were  allowed  to  bind  FITC-conjugated  heat-aggregated Ig,  the 
complexes were found  to be bound  randomly  to  the  lymphocyte surface,  not 
just  the portion bearing the Ig cap  (Fig.  1).  This result  provided strong evi- 
dence  that  surface  Ig  and  the  receptor  for  complexed  antibody  were  inde- 
pendent. The reverse experiment could not be performed because of the failure 
of bound complexes to cap (see below). 
FIG. 1.  Demonstration of the independence of surface Ig and the receptor for aggregated 
Ig.  (a)  Phase-contrast  illumination of two lymphocytes. One lymphocyte, under selective 
illumination  for rhodamine  (b)  reveals cap  formation with  TMRITC-conjugated  anti-Ig, 
and under selective illumination for fluorescein (c) reveals binding of FITC-conjugated aggre- 
gated Ig. The aggregated Ig is randomly bound to the cell surface, not just the portion bearing 
the surface Ig cap. X 900. 
Additional information on the nature of the receptor was obtained by study- 
ing  the  ability of lymphocytes which  had  been treated with enzymes to  bind 
aggregated Ig (Table V).  Lymphocytes treated with  trypsin, even at concen- 
trations  as  high  as  10  mg/ml,  retained  their  ability  to  bind  aggregated  Ig, 
whereas no  complexes were bound  when the  cells had  been treated  with pro- 
nasa. This suggested that the receptor was a trypsin-resistant protein or gluco- 
protein. These experiments also provided further evidence of the independence 
of the receptor and surface Ig, since the latter was trypsin sensitive. 
Cap  Formation  of  Lymphocyle-Bound Heat-Aggregated Ig  Complexes.-- 
Lymphocytes  were  allowed  to  bind  FITC-conjugated  heat-aggregated  Ig, 
washed,  and  then  incubated  in  medium  containing  FCS  for  varying  time 
periods at 37°C  (Table VI). The complexes appeared to be relatively stable on 
the cell surface under these conditions, and only a minority of the cells showed 
cap formation. The paucity of capping was not due to a lack of mobility of the HOWARD B.  DICKLER  515 
receptor  since  if  lymphocytes  bearing  FITC-conjugated  heat-aggregated  Ig 
complexes were exposed to unconjugated anti-Ig and then allowed to incubate 
at  37°C,  cap  formation  was  readily  apparent  (>90%  of  aggregate-positive 
cells). Thus, it appeared that the Ig complexes alone did not produce sufficient 
cross-linking of the receptor to allow cap formation. 
Role of the Receptor  in Antibody-Dependent  Lymphocyte-Mediated  Cytotoxic- 
ity.--Lymphocytes  were  allowed  to bind heat-aggregated  IgG and  then  were 
assayed  for  their  ability  to  lyse  antibody-coated  target  cells  (Table  VII). 
Lymphocytes which had bound IgG complexes were markedly inhibited in this 
immune  activity  as  compared  to  lymphocytes  pretreated  with  medium  or 
native  IgG.  In  addition,  lymphocytes which  had  bound  aggregated  IgG  did 
not show nonspecific toxicity for targets which had not been coated with anti- 
body. These results provided strong evidence that the receptor for complexed 
Ig plays  a  necessary  role  in  antibody-dependent  lymphocyte-mediated  cyto- 
toxicity,  and that binding of nonspecific complexes to the receptor is not suf- 
ficient to activate cytotoxic activity under these conditions. 
The  quantity  of aggregated IgG necessary  to inhibit  this  immune  activity 
was investigated  by varying the  amount  of complexes preincubated  with  the 
TABLE V 
Effect of Enzymatic Pretreatment of Lymphocytes on their Ability to Bind Heat-Aggregated Ig 
Enzymatic treatment* 
% Positives 
Exp. 1§  Exp. 2 
Aggregated  Ig  Aggregated  Ig  Surface  Ig  Surface Ig  binding  binding 
None  19.5  21.0  17.0  16.5 
Trypsin (2 mg/ml)  19.0  0.5  15.5  <0.5 
Trypsin (10 mg/ml)  20.0  <0.5  16.0  0.5 
Pronase  (1 mg/ml)  0.5  <0.5  1.0  <0.5 
* For details see Materials  and Methods. 
~; Minimum of 200 cells evaluated/preparation. 
§ Different blood donors and enzyme preparations  used in each experiment. 
TABLE VI 
Cap Formation o/Lymphocyte-Bound Heat-Aggregated Ig Complexes* 
Hours at 37°C  % of PBL binding  % of PBL with cap  aggregated Ig  formation:~ 
0  21.0  0.5 
1  18.5  2.0 
2  18.0  3.5 
4  13.5  4.5 
* For details see Materials  and Methods. Minimum of 200 cells evaluated/preparation. 
:~ Cap formation defined as surface fluorescence over <50% of cell surface. 516  STUDIES  OF  THE  LYMPHOCYTE  RECEPTOR  FOR  COMPLEXED  Ig 
attacking  lymphocytes  (Fig.  2).  A  minimum of 0.06 mg/2  X  107 lymphocytes 
was  necessary  to  produce  detectable  inhibition,  and  maximal  inhibition  was 
obtained with 2 mg/2  X  107 lymphocytes. Total inhibition was never obtained. 
This  may  have been  due  to  the fact  that  during  the 4-h  incubation  attacking 
cells may have generated  new receptors  and/or  IgG complexes may  have dis- 
sociated  from  some  receptors.  Nevertheless,  the  possibility  that  some  lyric 
TABLE VII 
Effect of Preincubation  of Nonimmune Lymphocytes with Heat-Aggregated Ig on their Ability to 
Lyse Antibody-Coated Target Cells* 
Preincubation$  Antibody-coating of  target cells  %  lysis 4- SEM§ 
Medium  No  --0.8  4-  0.5 
IgG  No  --1.1  4-  0.4 
Heat-aggregated IgG  No  0.6  ±  0.4 
Medium  Yes  52.1  4-  2.8 
IgG  Yes  56.8  4-  2.0 
Heat-aggregated IgG  Yes  16.7  -4-  1.6 
* For details see Materials and Methods. 
$ Both IgG preparations used at 2.0 mg/ml. 
§ t~o lysis of target cells incubated in medium alone was 9.9% and 9.70/0 for coated  and 
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Fro.  2.  Effect  of  preincubation  of  nonimmune  lymphocytes  with  various  amounts  of 
heat-aggregated Ig on their ability to lyse antibody-coated target cells. Each point represents 
the mean of quadruplicate samples with SEM indicated. Vertical dashed lines are drawn at 
concentrations  of aggregated IgG above and  below  which plateaus  were predicted  on  the 
basis of an identical and independent previous experiment. Horizontal solid  lines represent 
the means  of points between  those  concentrations.  Each  of these means was  significantly 
different from each of the other means (P <  0.005) as measured by Student's t test. HOWARD  B.  DICKLER  517 
activity was mediated by another mechanism not involving the receptor for 
complexed Ig could not be ruled out. 
Between the concentrations necessary to produce perceptible  and maximal 
inhibition,  the  dose-response  curve  was  not  linear  but  rather  two  plateaus 
were seen.  That  this  observation was  not  artifactual was  suggested by:  (a) 
the same phenomenon was observed in  three completely independent trials; 
(b) the concentrations above and below which plateaus were seen did not vary 
and were predictable from experiment to experiment; and,  (c)  the mean per- 
cent cytotoxicity for each of the predicted plateaus was significantly different 
(P  <  0.005)  from the means of every other plateau as measured by Student's 
t test. These data were consistent with the possibility that there may be more 
than one kind of receptor which may vary in affinity for Ig complexes and/or 
different populations of lymphocytes which vary in the number of receptors 
which they bear or in the topographical location of the receptors on their cell 
surface. 
DISCUSSION 
The human lymphocyte receptor for complexed Ig has been further char- 
acterized in the present studies. The specificity of the receptor was investigated 
by studying the binding of heat-aggregated preparations of both other proteins 
and Ig's which had undergone chemical modifications. Such preparations were 
equivalent (size, f/p ratio, and concentration) to heat-aggregated Ig complexes. 
Aggregates of HSA, BSA, and transferrin did not bind to lymphocytes, which 
suggested that the receptor is specific for complexed Ig. In addition, the site 
recognized by the receptor appears to involve the Fc portion of the Ig molecule, 
since  aggregated F(ab')2  did not  bind.  Studies in  the  murine system  (2,  3) 
are in agreement with this latter result.  Further, intact disulfide bond(s)  ap- 
pear to be required for the integrity of the site recognized by the receptor, since 
aggregates of mildly oxidized or reduced and alkylated Ig did not bind. Finally, 
inhibition experiments indicated that the same receptor binds both heat-ag- 
gregated Ig and Ig complexed to antigen. Thus, evidence was obtained that at 
least some of the  changes produced in the Ig molecule by heat aggregation 
mimic those effected by complexing antibody to antigen. This provides a basis 
for the use of heat-aggregated Ig complexes as a model to study the receptor. 
The evidence that lymphocyte surface Ig and the lymphocyte receptor for 
complexed Ig are distinct is now substantial. In addition to the present studies 
that showed independent capping of these two surface moieties and differential 
sensitivity to  trypsin, previous  reports  have indicated that  anti-Ig does not 
inhibit complexed Ig binding (2,  6),  and that in certain  disease states some 
PBL with no detectable surface Ig can nevertheless bind heat-aggregated Ig 
(7, 9). 
The inability of trypsin to  affect the binding of complexed Ig, previously 
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studies have shown that lymphocytes treated with pronase  are unable  to bind 
such complexes. This result suggested that the receptor  is a protein or glyco- 
protein. However, the possibility that the receptor is attached to the membrane 
by a pronase-sensitive protein could not be ruled out by the present studies. 
It is of interest to compare the lymphocyte binding of Ig complexes with that 
reported for macrophages  (18). The binding of Ig complexes to both lympho- 
cytes and macrophages  was inhibited by reduction and alkylation of the Ig, 
and not inhibited by pretreatment of the cells with trypsin. In contrast, lympho- 
cytes pretreated with pronase were unable to bind Ig complexes, which was not 
the case for macrophages  (although  in the macrophage  studies a much lower 
concentration of enzyme  was used).  Also, the macrophage  receptor  for com- 
plexed Ig appeared to have relative species specificity, whereas this has not been 
found for lymphocytes (binding and inhibition studies utilizing rabbit antibody- 
antigen  complexes and  heat-aggregated  human  Ig  complexes are  shown  in 
Tables III and IV. Also, see reference 1). However, differences in experimental 
design might account for  these  contrasting results.  Thus,  it remains  unclear 
whether the receptor sites  for complexed Ig on lymphocytes and macrophages 
are similar  or different. 
The hypothesis has been put forward that capping  of receptors  may play a 
role in lymphocyte triggering (17). Therefore, the ability of lymphocyte-bound 
heat-aggregated Ig complexes to cap was investigated.  Only a minority of cells 
with bound complexes showed cap formation when incubated for several hours 
at 37°C in FCS-supplemented  tissue culture medium.  However,  if such com- 
plexes were further cross-linked with anti-Ig, almost  all cells showed capping 
of the complexes. Thus, since movement of the receptor could be induced, this 
suggested that complexes alone do not produce sufficient cross-linking to allow 
cap formation. This could be explained by the receptor being univalent, or by 
lymphocytes having few receptors and/or the receptors being far apart on the 
cell surface. The present studies do not distinguish  between these possibilities. 
However,  the results  do imply that whatever the function(s)  of the receptor, 
marked movement of the receptor and/or the bound complexes is not required. 
Data from  several  laboratories  have suggested  that the receptor  for com- 
plexed Ig plays a role in antibody-dependent lymphocyte-mediated  cytotoxicity 
(19-23). This was directly evaluated in the present studies by assaying lympho- 
cytes which had bound heat-aggregated  IgG for their ability to lyse antibody- 
coated  target cells. Complexes bound under these  conditions  only affect  the 
receptor for complexed Ig in that no steric inhibition of other surface molecules, 
e.g. surface  Ig (see Table IV,  exp. 6),  and the C3  receptor  (5), has been de- 
tected.  Therefore,  the inhibition  of antibody-dependent lymphocyte-mediated 
cytotoxicity which  was  produced  by  the  bound  complexes provides  strong 
evidence for the requirement  of the receptor for complexed Ig in this immune 
activity. Further, the binding of nonspecific complexes (heat-aggregated  IgG) 
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the receptor. A possible interpretation of this latter result is that the receptor 
serves as a recognition and attachment mechanism but that cytotoxic activity 
is activated by some other means. 
When the  amount of heat-aggregated IgG needed to inhibit cytotoxic ac- 
tivity was investigated, an unexpected observation resulted: Between the con- 
centrations of complexes needed to produce perceptible and maximal inhibition 
the dose-response  curve was  not linear but  rather showed distinct plateaus. 
This suggested that there may be more than one kind of receptor for complexed 
Ig and/or different subpopulations which bear the receptor. The previous ob- 
servation that normal lymphocytes which bind complexed Ig are very heteroge- 
neous in  the  amount bound  (6),  whereas  "clonal"  lymphocyte populations 
~re  relatively homogenous (7),  is  consistent with  these  two possibilities but 
:ioes not distinguish between them. With regard to the possibility of different 
subpopulations bearing the receptor,  the responsible cytotoxic cell in the test 
system used in these studies has been defined as an Ig-bearing, nonphagocytic, 
nonadherent lymphocyte.  4 Such lymphocytes could be either B cells or lympho- 
cytes bearing both B- and T-cell markers (8). While the exact nature of these 
latter cells  is unknown, it is conceivable that they may be activated T  cells 
since some T  lymphocytes can absorb cytophilic antibody (24),  and activated 
T  cells apparently bear the receptor for complexed Ig (25, 26). Thus, the dif- 
ferent lymphocyte populations involved in  antibody-dependent lymphocyte- 
mediated cytotoxicity may be B cells and activated T  cells. Alternatively, sub- 
populations of B lymphocytes may exist. Studies are in progress using a fluores- 
cent-activated cell sorter in an attempt to answer these questions. 
While the receptor for complexed Ig appears to perform a necessary function 
in  antibody-dependent  lymphocyte-mediated cytotoxicity, it  cannot  be  as- 
sumed that this is the only or even the most important role of this receptor. 
In view of the accumulating evidence for the existence and functional properties 
of T-cell Ig (27-30),  the possibility should be considered that the lymphocyte 
receptor for complexed Ig plays a role in cell-cell cooperation and regulation of 
the immune response. 
SUMMARY 
The lymphocyte receptor for complexed immunoglobulin was shown not to 
bind heat-aggregated human serum albumin, bovine serum albumin, transfer- 
tin, F(ab')~, reduced and alkylated Ig, and mildly oxidized Ig, which indicated 
that the receptor is specific for a site dependent on disulfide bond(s) on the Fc 
portion of complexed Ig.  Inhibition experiments provided  evidence that  the 
same receptor binds both heat-aggregated Ig and antigen-antibody complexes. 
Lymphocytes treated with pronase were no longer able to bind Ig complexes, 
which  suggested  that  the  receptor  is  a  protein  or  glycoprotein.  Additional 
4 Yust, I., N. F. Adkinson, Jr., H. B. Dickler, R. W. Smith, R. H. Schwartz, S. O. Sharrow, 
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evidence was obtained that lymphocyte surface Ig and  the receptor for com- 
plexed Ig are distinct since the former could be capped without affecting the 
distribution of the latter, and surface Ig was not detectable after trypsinization 
of lymphocytes, whereas  the binding of Ig complexes was unaffected by such 
treatment. Incubation of lymphocytes which had bound Ig complexes in tissue 
culture medium at 37°C revealed that the complexes remained on the surface 
membrane for several hours, and that only a minority of lymphocytes binding 
complexes showed cap formation. 
Lymphocytes which  had  heat-aggregated  IgG  specifically  bound  to  their 
receptors for complexed Ig were markedly inhibited in their ability to mediate 
antibody-dependent  cytotoxicity,  thus  providing  strong  evidence  for  the 
necessity of the receptor in  this immune activity. Titration of this inhibition 
with  varying  amounts  of  complexes  revealed  distinct  plateaus  in  the  dose- 
response curve. This suggested that  there may be more than one kind of re- 
ceptor and/or different populations of lymphocytes which bear the receptor. 
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